Search research articles
Contact Us
Filters
Showing results (311-320 of 411) with videos related to
Page
of 42
Sort By:
Lancet (London, England)
|
August 24, 1991
Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapy
A L Jones, A S Hill, M Soukop, et al.
European Journal of Cancer & Clinical Oncology
|
February 1, 1984
The treatment of advanced bladder cancer with methotrexate and cis-platinum--a pharmacokinetic study
S B Kaye, D McWhinnie, A Hart, et al.
Cancer Treatment Reports
|
March 1, 1984
Sequential methotrexate plus 5-FU in advanced breast and colorectal cancers: a phase II study
S B Kaye, G Sangster, A Hutcheon, et al.
British Journal of Cancer
|
July 29, 2010
A retrospective analysis of clinical outcome of patients with chemo-refractory metastatic breast cancer treated in a single institution phase I unit
A T Brunetto, D Sarker, D Papadatos-Pastos, et al.
Cancer Research
|
May 15, 1992
Phase I and pharmacokinetic study of rhizoxin
D Bissett, M A Graham, A Setanoians, et al.
British Journal of Cancer
|
October 29, 2002
Phase I study of docetaxel in combination with cyclophosphamide as first-line chemotherapy for metastatic breast cancer
P A Vasey, H Roché, D Bisset, et al.
European Journal of Cancer & Clinical Oncology
|
December 1, 1986
4'Deoxydoxorubicin in advanced renal cancer. A phase II study in previously untreated patients from the EORTC Genito-Urinary Tract Cancer Cooperative Group
A T van Oosterom, A V Bono, S B Kaye, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry
|
November 24, 1999
Monocular and binocular depth discrimination thresholds
S B Kaye, A Siddiqui, A Ward, et al.
Cancer Research
|
December 15, 1987
Phase I and pharmacokinetic study of flavone acetic acid
D J Kerr, S B Kaye, J Cassidy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 1994
Phase II studies of Elsamitrucin in breast cancer, colorectal cancer, non-small cell lung cancer and ovarian cancer. EORTC Early Clinical Trials Group
J Verweij, J Wanders, A L Nielsen, et al.
Page
of 42
Search research articles
Search
Showing results (311-320 of 411) with videos related to
Sort By:
Page
of 42
Lancet (London, England)
|
August 24, 1991
Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapy
A L Jones, A S Hill, M Soukop, et al.
European Journal of Cancer & Clinical Oncology
|
February 1, 1984
The treatment of advanced bladder cancer with methotrexate and cis-platinum--a pharmacokinetic study
S B Kaye, D McWhinnie, A Hart, et al.
Cancer Treatment Reports
|
March 1, 1984
Sequential methotrexate plus 5-FU in advanced breast and colorectal cancers: a phase II study
S B Kaye, G Sangster, A Hutcheon, et al.
British Journal of Cancer
|
July 29, 2010
A retrospective analysis of clinical outcome of patients with chemo-refractory metastatic breast cancer treated in a single institution phase I unit
A T Brunetto, D Sarker, D Papadatos-Pastos, et al.
Cancer Research
|
May 15, 1992
Phase I and pharmacokinetic study of rhizoxin
D Bissett, M A Graham, A Setanoians, et al.
British Journal of Cancer
|
October 29, 2002
Phase I study of docetaxel in combination with cyclophosphamide as first-line chemotherapy for metastatic breast cancer
P A Vasey, H Roché, D Bisset, et al.
European Journal of Cancer & Clinical Oncology
|
December 1, 1986
4'Deoxydoxorubicin in advanced renal cancer. A phase II study in previously untreated patients from the EORTC Genito-Urinary Tract Cancer Cooperative Group
A T van Oosterom, A V Bono, S B Kaye, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry
|
November 24, 1999
Monocular and binocular depth discrimination thresholds
S B Kaye, A Siddiqui, A Ward, et al.
Cancer Research
|
December 15, 1987
Phase I and pharmacokinetic study of flavone acetic acid
D J Kerr, S B Kaye, J Cassidy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 1994
Phase II studies of Elsamitrucin in breast cancer, colorectal cancer, non-small cell lung cancer and ovarian cancer. EORTC Early Clinical Trials Group
J Verweij, J Wanders, A L Nielsen, et al.
Page
of 42